Olga Sevryugin1, Popi Kasvis1,2, MariaLuisa Vigano2,3, Antonio Vigano4,5. 1. Supportive and Palliative Care Division, McGill University Health Centre, 1001 Decarie Boulevard, Montreal, Quebec, H4A 3J1, Canada. 2. McGill Nutrition and Performance Laboratory (MNUPAL), Suite 105B, Place Vendome, 5252 de Maisonneuve Blvd West, Montreal, Quebec, H4A 3S5, Canada. 3. Faculty of Science, McGill University, Montreal, Quebec, Canada. 4. Supportive and Palliative Care Division, McGill University Health Centre, 1001 Decarie Boulevard, Montreal, Quebec, H4A 3J1, Canada. antonio.vigano@mcgill.ca. 5. McGill Nutrition and Performance Laboratory (MNUPAL), Suite 105B, Place Vendome, 5252 de Maisonneuve Blvd West, Montreal, Quebec, H4A 3S5, Canada. antonio.vigano@mcgill.ca.
Abstract
PURPOSE: Taste and smell disturbances in patients affected by cancer are very common, but often under-recognized symptoms. If not addressed properly, they may impact nutritional status, food enjoyment, and quality of life. Treatment tools available for clinicians to manage chemosensory alterations are limited and are often based on personal clinical experiences. The aim of this study was to assess current oncological and palliative care literature through a scoping review, in order to identify available treatments for taste and smell alterations in cancer patients. METHODS: Medline, Embase, CINAHL, ProQuest Dissertations and Theses, and Google Scholar were searched from inception until January 2020, with subject headings relevant to the domains of chemosensory alterations, palliative, and cancer care. A total of 10,718 English and French language publications were reviewed, yielding 43 articles on the researched topic. RESULTS: The heterogeneity of selected articles led to difficulties in interpretation and analysis of the available evidence. Included publications differed in study design, population sample, anticancer treatments, and measures of assessment for taste and smell disturbances. A broad variety of treatment options were described including zinc and polaprezinc, radio-protectors, vitamins and supplements, anti-xerostomia agents, active swallowing exercises, nutritional interventions, delta-9-tetrahydrocannabinol, and photobiomodulation. CONCLUSION: This scoping review identifies the current state of knowledge regarding chemosensory alterations within supportive cancer care. Despite not reaching firm conclusions, this article offers therapeutic venues to further explore in larger and more methodologically sound studies.
PURPOSE: Taste and smell disturbances in patients affected by cancer are very common, but often under-recognized symptoms. If not addressed properly, they may impact nutritional status, food enjoyment, and quality of life. Treatment tools available for clinicians to manage chemosensory alterations are limited and are often based on personal clinical experiences. The aim of this study was to assess current oncological and palliative care literature through a scoping review, in order to identify available treatments for taste and smell alterations in cancer patients. METHODS: Medline, Embase, CINAHL, ProQuest Dissertations and Theses, and Google Scholar were searched from inception until January 2020, with subject headings relevant to the domains of chemosensory alterations, palliative, and cancer care. A total of 10,718 English and French language publications were reviewed, yielding 43 articles on the researched topic. RESULTS: The heterogeneity of selected articles led to difficulties in interpretation and analysis of the available evidence. Included publications differed in study design, population sample, anticancer treatments, and measures of assessment for taste and smell disturbances. A broad variety of treatment options were described including zinc and polaprezinc, radio-protectors, vitamins and supplements, anti-xerostomia agents, active swallowing exercises, nutritional interventions, delta-9-tetrahydrocannabinol, and photobiomodulation. CONCLUSION: This scoping review identifies the current state of knowledge regarding chemosensory alterations within supportive cancer care. Despite not reaching firm conclusions, this article offers therapeutic venues to further explore in larger and more methodologically sound studies.
Authors: Javier Amézaga; Begoña Alfaro; Yolanda Ríos; Aitziber Larraioz; Gurutze Ugartemendia; Ander Urruticoechea; Itziar Tueros Journal: Support Care Cancer Date: 2018-05-31 Impact factor: 3.603
Authors: C Ripamonti; E Zecca; C Brunelli; F Fulfaro; S Villa; A Balzarini; E Bombardieri; F De Conno Journal: Cancer Date: 1998-05-15 Impact factor: 6.860
Authors: A van der Werf; M Rovithi; J A E Langius; M A E de van der Schueren; H M W Verheul Journal: Eur J Cancer Date: 2017-10-04 Impact factor: 9.162
Authors: S S Gill; J Frew; A Fry; J Adam; V Paleri; W Dobrowsky; S Chatterjee; C G Kelly Journal: Clin Oncol (R Coll Radiol) Date: 2011-05-06 Impact factor: 4.126
Authors: L Spotten; C Corish; C Lorton; P Ui Dhuibhir; N O'Donoghue; B O'Connor; M Cunningham; N El Beltagi; C Gillham; D Walsh Journal: Support Care Cancer Date: 2016-03-05 Impact factor: 3.603
Authors: Anne Kathrine Larsen; Christine Thomsen; Mathilde Sanden; Lotte Boa Skadhauge; Camilla Bundgaard Anker; Marie Nerup Mortensen; Wender L P Bredie Journal: Support Care Cancer Date: 2021-06-02 Impact factor: 3.603
Authors: Sara C Parke; David Michael Langelier; Jessica Tse Cheng; Cristina Kline-Quiroz; Michael Dean Stubblefield Journal: Curr Oncol Rep Date: 2022-02-19 Impact factor: 5.075
Authors: Glenn J Lesser; Megan B Irby; Richard C Taylor; Anna Snavely; Douglas Case; Aili Wang; Andrea Dietrich; Susan Duncan Journal: Support Care Cancer Date: 2021-10-13 Impact factor: 3.359